Genethon Company Profile

20:30 EDT 24th September 2017 | BioPortfolio

Genethon produces recombinant viral vectors for gene transfer. The vectors can be used for research or preclinical studies. GMP grade vector preparations will be available in the near future.
We can either amplify a vector that you are currently using, or design and produce one with the features you need. Initial DNA constructs are assembled, starting from elements you provide to Genethon.

You project will come as a regular service or as part of a privileged scientific partnership with Genethon. All services will be invoiced.


1bis, rue de l'internationale - BP 60
Evry cedex



News Articles [15 Associated News Articles listed on BioPortfolio]

Spark, Genethon enter licensing agreement to develop AAV gene therapies

A licensing agreement was signed by Spark Therapeutics and Genethon to collaborate on the development and commercialization o -More- 

Sarepta, Genethon collaborate for Duchenne muscular dystrophy

Sarepta Therapeutics, Inc., a U.S. commercial-stage biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics for the treatment of rare neuromuscular disea...

Sarepta, Genethon to research muscular dystrophy treatment

Sarepta Therapeutics and Genethon have agreed to conduct joint gene-therapy research into Duchenne muscular dystrophy, combin -More- 

Sarepta Therapeutics and Genethon announce gene therapy research collaboration for Duchenne muscula

(AFM-Téléthon) Sarepta Therapeutics, Inc. (NASDAQ:SRPT), and Genethon have signed a gene therapy research collaboration to jointly develop treatments for Duchenne muscular dystrophy (DMD).

Sarepta and Genethon Enter Gene Therapy Research Collaboration for Duchenne Muscular Dystrophy Treatments

CAMBRIDGE, Mass. and EVRY, France, June 21, 2017 (GLOBE NEWSWIRE) — Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a U.S. commercial-stage biopharmaceutical company focused on the discovery and devel...

Sarepta gets option for Genethon's DMD gene therapy

Spark Therapeutics Enters Into Licensing Agreement With Genethon

  Life Sciences Jobs   ...

Sarepta Announces Its Partner, Genethon, Published New Micro-Dystrophin Gene Therapy Data In /i>

  Life Sciences Jobs   ...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [0 Results]


More Information about "Genethon" on BioPortfolio

We have published hundreds of Genethon news stories on BioPortfolio along with dozens of Genethon Clinical Trials and PubMed Articles about Genethon for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Genethon Companies in our database. You can also find out about relevant Genethon Drugs and Medications on this site too.

Quick Search

Relevant Topics

Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

DNA sequencing
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Corporate Database Quicklinks

Searches Linking to this Company Record